A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 581
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DMPA
Long Form : depot medroxyprogesterone acetate
No. Year Title Co-occurring Abbreviation
2020 An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy. BMD
2020 Bones and Birth Control in Adolescent Girls. ---
2020 Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers. CTLA-4, NET-EN, PD-1
2020 Informing Policy Change: A Study of Rapid Repeat Pregnancy in Adolescents to Increase Access to Immediate Postpartum Contraception. AOR, ENG, RRP
2020 Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1. NET-EN
2019 ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. HIV, USMEC
2019 ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. HIV, USMEC
2019 Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women. HIV-1, IUDs, STIs
2019 Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection. HC, HIV, NET-EN
10  2019 Being on the Safe Side: A Qualitative Study of Condom Use Motivations According to Contraceptive Type among Adolescents in Atlanta, Georgia. LARC, STI
11  2019 Changes in calcium metabolism and bone mineral density in new users of medroxyprogesterone acetate during the first year of use. ANOVA, BMD, IUD
12  2019 Changes in US health care provider attitudes related to contraceptive safety before and after the release of National Guidance. IUDs
13  2019 Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives. ALLO, CHC, IUDs, LNG, PMDD, PMS, POP, SSRIs
14  2019 Depot medroxyprogesterone acetate and the vaginal microbiome as modifiers of tenofovir diphosphate and lamivudine triphosphate concentrations in the female genital tract of Ugandan women: Implications for TDF/3TC in pre-exposure prophylaxis. FGT, TFV-DP
15  2019 Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk. HRs, IUD, OCP
16  2019 Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion. C-CAM, DSC1, Dsg1a, HSV-2
17  2019 Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women. F/B, L/P, VNAB
18  2019 Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion. CI, FSWs, OCPs
19  2019 Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users. CV, OCP, PKs
20  2019 Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood. ETG, LNG-IUD
21  2019 Empowering Adolescent Mothers in the Choice of Contraceptive Methods at the Postpartum Period: Avoiding a Subsequent Pregnancy. IUC, LARC
22  2019 Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers. AORs, CIs
23  2019 Familiarity and acceptability of long-acting reversible contraception and contraceptive choice. FQHCs, IUD, LARC, OCPs
24  2019 Gynecologic Management of Pediatric and Adolescent Patients with Ehlers-Danlos Syndrome. EDS, HMB, ICD, IUD, PAG
25  2019 Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents. AORs, CHC, CIs
26  2019 Health Care Provider Attitudes Toward Safety of Selected Hormonal Contraceptives in Breastfeeding Women. AOR, CI, COCs
27  2019 Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia. aHRs, HIV
28  2019 Hormonal Contraceptives and the Acquisition of Sexually Transmitted Infections: An Updated Systematic Review. HC, HPV, HSV-2, NET-EN, STIs
29  2019 Improving access to contraception through integration of family planning services into a multidrug-resistant tuberculosis treatment programme. MDR-TB
30  2019 Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate. ---
31  2019 Menstrual cycle-dependent alterations in glycosylation: a roadmap for defining biomarkers of favorable and unfavorable mucus. IUD
32  2019 Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate (DMPA) in African women receiving treatment for HIV and TB: Potential concern for standard dosing frequency. ART, MPA, TB
33  2019 Postpartum hormonal contraception in breastfeeding women. IPP, IUD, LNG
34  2019 Prevalence of Documented Excessive Weight Gain Among Adolescent Girls and Young Women Using Depot Medroxyprogesterone Acetate. CI
35  2019 Protective effect of green tea on tunica adventitia and endothelial changes resulting from depot medroxy progesterone acetate. ---
36  2019 Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate: A Systematic Review. ---
37  2019 The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition. CV, HCs, OCPs
38  2019 Thyroid function during the first year of use of the injectable contraceptive depot medroxyprogesterone acetate. BMI, IUD
39  2019 Use of reliable contraceptives and its correlates among women participating in Simulated HIV vaccine efficacy trials in key-populations in Uganda. IUD, SiVETs
40  2019 Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum. VTE
41  2019 What impact could DMPA use have had in South Africa and how might its continued use affect the future of the HIV epidemic? ---
42  2018 A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy. COCs, HC, RANTES, SLPI
43  2018 Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status. BMD, BMI, COCs, FSH, NET-EN
44  2018 Cause or Coincidence? Spontaneous Hematometra in Young Women Receiving Depomedroxyprogesterone Acetate: A Small Case Series. ---
45  2018 Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives. BV, COC, LNG-IUS, STIs
46  2018 Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis. FDA, NETA, PK
47  2018 Decreasing trends in number of depot medroxyprogesterone acetate starters in Norway - a cross-sectional study. ---
48  2018 Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review. ---
49  2018 Differential expressions of estrogen and progesterone receptors in endometria and cyst walls of ovarian endometrioma from women with endometriosis and their responses to depo-medroxyprogesterone acetate treatment. ERs, PRs
50  2018 Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice. DSG-1, hPBMC-NSG, hPBMCs, HSV-2, IVAG, LMW, NSG
51  2018 Exposure to routine availability of immediate postpartum LARC: effect on attitudes and practices of labor and delivery and postpartum nurses. LARC
52  2018 Hyperinsulinemic-euglycemic clamp over the first year of use of depot-medroxyprogesterone acetate as a contraceptive. HEC, IR, IUD
53  2018 MOBILE-izing Adolescent Sexual and Reproductive Health Care: A Pilot Study Using a Mobile Health Unit in Chicago. EC, MHUs, OCPs, SRHC
54  2018 Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques. COCs, EE, LNG, SHIV
55  2018 Risk factors for ectopic pregnancy in a population of Cameroonian women: A case-control study. AOR, CIs, EP, IUP, LNG-EC, OR, PID
56  2018 Subclinical cardiovascular disease parameters after one year in new users of depot medroxyprogesterone acetate compared to copper-IUD. ANOVA, BMI, IUD
57  2018 Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity. COC, IPA, USAID
58  2018 Why Didn't You Text Me? Poststudy Trends From the DepoText Trial. RCT
59  2017 A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities. ART, LNG
60  2017 Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up. BMR, BS, REE, RQ
61  2017 Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate. BMD
62  2017 Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization-The impact oftheboxed warning. BMD, BPA, CHC
63  2017 Community Health Workers as Social Marketers of Injectable Contraceptives: A Case Study from Ethiopia. CBD, HEWs
64  2017 Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion. ---
65  2017 Contraception Update: Progestin-Only Implants and Injections. ---
66  2017 Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. COCs, HR
67  2017 Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users: a prospective observational study. LNG-IUS, PI, RI
68  2017 Effect of the injectable contraceptive depot-medroxyprogesterone acetate on coagulation parameters in new users. BMI, IUD
69  2017 Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. AOR, BV, CI, COCs, LNG-IUS, STIs
70  2017 Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial. IPC, IUD, RCT
71  2017 Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study. CI
72  2017 Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices. ---
73  2017 Healthcare Provider Attitudes Regarding Contraception for Women with Obesity. AORs, CIs, COCs, IUDs, LNG
74  2017 High dose of green tea infusion normalized spiral artery density in rats treated with the depot-medroxyprogesterone acetate. GT
75  2017 High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception. OCP
76  2017 Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception. Yc
77  2017 Postpartum family planning: missed opportunities across the continuum of care FP, RDHS
78  2017 Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial. ECHO, IUD, LARC, LNG
79  2017 Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings. IVR, TDF, TFV
80  2017 The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK. ---
81  2017 Thrombin impairs human endometrial endothelial angiogenesis; implications for progestin-only contraceptive-induced abnormal uterine bleeding. CSPG4, ELISA, HEECs, HESC, PCR, rh
82  2017 Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection. HIV, U.S. MEC, WHO
83  2017 Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada. HSV-2, PY
84  2016 A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk. SHIV, SIV
85  2016 Adolescent Contraception Before and After Pregnancy-Choices and Challenges for the Future. CAISM, LARCs
86  2016 An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. ---
87  2016 Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness. aHR, ART, CI, COCs, IUD
88  2016 Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate. BES, BMI, IUD
89  2016 Cardiovascular Disease Risk Associated With the Long-term Use of Depot Medroxyprogesterone Acetate. LDL
90  2016 Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate. IL
91  2016 Comparison of two strategies for the administration of injectable depot medroxyprogesterone acetate: among women who returned to a family planning clinic at three- or six-month intervals. ---
92  2016 Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery. VTE
93  2016 DMPA Suppresses Cell Proliferation and Enhances Cell Apoptosis of Eutopic Endometrium in Women with Endometriosis: A Randomized Controlled Study. ---
94  2016 Eating disorders, menstrual dysfunction, weight change and DMPA use predict bone density change in college-aged women. AA, BMD, EDI, OCs
95  2016 Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women. cART, CMI, MPA, Treg
96  2016 Injectable contraception: updates and innovation. ---
97  2016 Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use. BMI, HOMA, HOMA-IR
98  2016 Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States. AOR, CI, DMPA-SC
99  2016 Long-Term Clinical Outcomes in Diabetic Rhesus Macaques (Macaca mulatta) Treated with Medroxyprogesterone Acetate for Endometriosis. DM
100  2016 Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. DSG1alpha, HSV-2, LNG, STI